Funding Decisions

Movember Discovery Grants

June 10, 2015 - Prostate Cancer Canada and Movember are proud to announce the recipients of the 2015 Movember Discovery Grants. The main goal of this program is to support researchers in that key stage of obtaining early results. The program supports both junior investigators early in their carrer and allows more established investigators to pursue new important directions. Applications are accepted from all areas of prostate cancer research. The goal is to support researchers to generate preliminary data in prostate cancer research that would provide the basis for a more substantial research grant in the future.

The applications are evaluated by a rigorous peer-review process that assess the track record of investigator and team, the feasibility of the proposed work, innovation and the potential impact on prostate cancer.

This represents an investment of $2,400,000 over 2 years starting July 1, 2015.

 

Principal Investigator Institution Project Title Funded Amount
Tommy Alain Children's Hospital of Eastern Ontario Research Institute
Ottawa, ON
Deciphering the fundamental implications of LARP1 in mTORC1-addicted prostate cancer $190,000
Alice Dragomir Research Institute of the McGill University Health Centre
Montreal, QC
Development of a clinical and economic model for evaluating new tests or strategies of diagnosis, treatment and management of prostate cancer $181,515
Robert Hamilton University Health Network
Toronto, ON
Molecular characterization and behavior of tumours arising in patients taking 5-alpha reductase inhibitors $199,961
Cheryl Helgason BC Cancer Agency
Vancouver, BC
Functional analysis of PCAT18 $184,000
Stanley Liu Sunnybrook Research Institute
Toronto, ON
MicroRNA as mediators of radioresistance in prostate cancer patients $87,567
Julian Lum BC Cancer Agency
Vancouver, BC
Exploiting the immune effects of androgen deprivation and radiotherapy for the treatment of high-risk prostate cancer $188,500
Ivan Topisirovic Jewish General Hospital
Montreal, QC
Resolving gene expression landscapes in prostate cancer through ex-vivo modelling of stromal-epithelial cross-talk $87,567
Michel Tremblay McGill University
Montreal, QC
Characterization and prognostic potential of the prostate cancer genetic-susceptibility amplicon on chromosome 20q13 during tumour progression $197,322
Dominique Trudel Centre de recherche du Centre Hositalier de l'Université de Montréal
Montreal, QC
Adaptation of inelastic scattering detection technology for label-free molecular imaging to improve the reliability of prostatic biopsies $199,000
Franco Vizeacoumar University of Saskatchewan
Saskatoon, SK
Validating synthetic dosage lethal interactions of PLK1 in androgen-insensitive prostate cancer cells $87,567
Jian Hui Wu Jewish General Hospital
Montreal, QC
Development of human STING agonists for prostate cancer immunotherapy  $200,000
Alexander Wyatt University of British Columbia
Vancouver, BC
Circulating biomarkers of cabazitaxel response and progression in castration-resistant prostate cancer $197,000
Roger Zemp University of Alberta
Edmonton, AB
Nano- and imaging platforms for prostate cancer personalized medicine $200,000
Gang Zheng University Health Network
Toronto, ON
Harnessing the microbubble to nanoparticle conversion for photodynamic therapy of recurrent prostate cancer $200,000




Movember Team Grant

June 10, 2015 - Prostate Cancer Canada and Movember are proud to announce the recipient of the 2015 Movember Team Grant. Team grant funding supports integrated, multi-disciplinary research programs involving high-quality independent investigators who share knowledge and resources while working towards a unifying overall scientific goal. The successful team must propose a well-defined program of research that encompasses several aspects of prostate cancer research that are clearly interrelated and synergistic so that efforts and outcomes have more impact than if funded as separate grants. The program must have participating principal investigators from a minimum of three institutions and provide a formal training program.  

An international panel of reviewers was assembled to adjudicate the team grants competition. The applications were submitted to a multi-stage and layered review process; narrowing the field to a short list of applicant teams invited to a reverse site visit in Toronto.

This represents a total investment of $4,995,400 over five years starting July 1, 2015.

 
Program Director and Principal Investigator Institution Project Title Funded Amount
John Bell Ottawa Hospital Research Institute
Ottawa, ON
Development of a targeted oncolytic virus vaccine for the treatment of metastatic prostate cancer $4,990,498
Team Members: Institutions:
Jean-Simon Diallo
Co-Principal Investigator
Ottawa Hospital Research Institute
Ottawa, ON
Sébastien Hotte
Co-Principal Investigator
McMaster University
Hamilton, ON
Brian Lichty
Co-Principal Investigator
McMaster University
Hamilton, ON
Fred Saad
Co-Principal Investigator
Centre Hospitalier de l'Université de Montréal
Montreal, QC
Eric Belanger
Co-Investigator
Ottawa Hospital
Ottawa, ON
Jonathan Bramson
Co-Investigator
McMaster University
Hamilton, ON
Rodney Breau
Co-Investigator
Ottawa Hospital Research Institute
Ottawa, ON
Dean Fergusson
Co-Investigator
Ottawa Hospital Research Institute
Ottawa, ON
Derek Jonker
Co-Investigator
University of Ottawa
Ottawa, ON
Andrea McCart
Co-Investigator
University of Toronto
Toronto, ON
David Stojdl
Co-Investigator
Children's Hospital of Eastern Ontario
Ottawa, ON
Yonghong Wan
Co-Investigator
McMaster University
Hamilton, ON


 

Movember True NTH Survivorship Research Grants

March 27, 2015 - Prostate Cancer Canada (PCC) and Movember are proud to announce the results of the Movember Targeted RFA in Survivorship Research competition. Projects aim to inform the development and delivery of interventions and best practices in follow-up care for cancer patients, survivors and their families and caregivers.

Three grants have been funded starting April 1, 2015, representing a total investment of $2,065,895 over the next three to five years.
 
Principal Investigator Institution Project Title Funded Amount
Shabbir Alibhai University Health Network
Toronto, ON
Toward personalizing care for older men with mCRPC - Princess Margaret Cancer Centre, University Health Network and predicting treatment toxicities
(the TOPCOP study)
$413,830
Jennifer Jones University Health Network
Toronto, ON
Prostate Cancer Survivorship 360° $1,281,025
Sylvie Lambert McGill University
Montreal, QC
Reducing anxiety and enhancing quality of life among caregivers of prostate cancer survivors: Development and evaluation of a dyadic, tailored, web-based, psychosocial and physical activity self-management programme $434,040

 

Movember Clinical Trial in Prostate Cancer

March 20, 2015 - Prostate Cancer Canada (PCC) and Movember are proud to announce the results of the Movember Clinical Trials in Prostate Cancer competition. Applications were accepted for investigator-initiated clinical trials studying the iatrogenic effects of prostate cancer treatment with an overall aim of mitigating effects that are unintended and unwanted.

One grant has been funded starting April 1, 2015, representing a total investment of $3,449,136 over a five-year term.

 
Principal Investigator Institution Project Title Funded Amount
Jehonathan Pinthus McMaster University Role of androgen deprivation therapy in cardiovascular disease - a longitudinal prostate cancer study (RADICAL PC) $3,449,136


 

Rising Stars in Prostate Cancer Research

December 15, 2014 – Prostate Cancer Canada is pleased to announce the successful candidates from the Rising Stars in Prostate Cancer Research. These awards provide salary and research support for outstanding researchers initiating a career as independent investigators in prostate cancer research. These awards provide the opportunity for research scientists within the first 5 years of their first academic or research appointment to develop and demonstrate independence in initiating and conducting prostate cancer research.

This opportunity is proudly funded in part by the Movember Foundation. Each award is for three years to a maximum of $450,000.
 
Rising Stars in Prostate Cancer Research
Award Principal Investigator Institution Title Funded Amount
Movember Rising Star in Prostate Cancer Research Andrei Drabovich University Health Network
Toronto, ON
Bridging genomics and proteomics to identify protein biomarkers for stratification of prostate cancer aggressiveness $450,000
Movember Rising Star in Prostate Cancer Research Dominique Trudel Centre de Recherche du Centre Hospitalier de l'Université de Montreal
Montreal, QC
Intraductal carcinoma of the prostate: Imaging mass spectrometry for an in situ prognostic oriented characterization $438,985
Prostate Cancer Canada/Movember Rising Star in Prostate Cancer Research Lauren Walker University of Calgary
Calgary, AB
Prostate cancer and sexual recovery $446,705
Movember Rising Star in Prostate Cancer Research Aaron Ward University of Western Ontario
London, ON
Multi-modality radiomics for personalized prostate cancer care $447,856
 

 

Post Doctoral Research Fellowships in Prostate Cancer Research

December 15, 2014 - Prostate Cancer Canada (PCC) is pleased to announce Post-Doctoral Research Fellowship awards, which provide a stipend for outstanding trainees at the post-PhD degree stages, conducting prostate cancer research. Each award is $60,000 for one year.
 
Post Doctoral Research Fellowship in Prostate Cancer
Award Fellow Institution Title Funded Amount
Derek Page, Oxford Properties Postdoctoral Research Fellowship Miriam Butler
 
Vancouver Prostate Centre
Vancouver, BC
Small molecule inhibition of ETS factors in prostate cancer $60,000
Edward Sorbara Postdoctoral Research Fellowship Jinqiang Hou Lawson Health Research Institute
London, ON
The development of radiolabelled GHSR-1a small molecule ligands for the accurate diagnosis of prostate cancer using PET $60,000
PCC Postdoctoral Research Fellowship Kirsi Ketola Vancouver Prostate Centre
Vancouver, BC
Targeting enzalutamide resistant prostate cancer stem cell phenotype $60,000

 

Graduate Studentships in Prostate Cancer Research

December 15, 2014 - Prostate Cancer Canada (PCC) is pleased to announce Graduate Studentships in Prostate Cancer Research which provide a stipend for outstanding graduate students conducting prostate cancer research. Each award is $40,000 for one year.
 
Graduate Studentships in Prostate Cancer Research
Award Student Institution Title Funded Amount
George Mohasci Graduate Studentship Mohammad Ali Amini University of Toronto
Toronto, ON
Hybrid bioactive nanoparticles for modulating prostate tumor microenvironment and enhancing radiation therapy $40,000
Edward Nash Graduate Studentship Fredéric Couture Université de Sherbrooke
Sherbrooke, QC
Validation of PACE4 potential for prostate cancer diagnosis $10,000
Sam Ciccolini Graduate Studentship Jeff Gaudet University of Western Ontario
London, ON
Imaging cancer immunotherapy: Development of MRI for in vivo tracking of cell-based therapies $40,000
John Winter Graduate Studentship Sze Ue (Iris) Luk University of British Columbia
Vancouver, BC
Role of BIRC6 in prostate cancer: Clinical relevance, functional characterization & therapeutic targeting $40,000
Steve Hutton Graduate Studentship Christopher Pinelli University of Guelph
Guelph, ON
Role of chronic inflammation and proteases in the emergence of castration-resistant prostate cancer $40,000
Kenneth Odell Graduate Studentship Maxwell Shafer McGill University
Montreal, QC
The role of Gata3 in the regulation of prostate cancer stem cell homeostasis $40,000
Ellis Don Graduate Studentship Kevin Tam Vancouver Prostate Centre
Vancouver, BC
Semaphorin 3C drives epithelial-to-mesenchymal transition and stem-like properties in prostate cells $40,000




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
4 Canadians deemed Rising Stars in Prostate Cancer Research

Toronto, ON - June 29, 2015: Prostate Cancer Canada (PCC) is proud to announce four awardees of Rising Stars in prostate cancer research grants.
More

14 innovative Canadian minds set out to make new discoveries in prostate cancer research grants awarded by Movember Foundation and Prostate Cancer Canada

Toronto, ON - June 25, 2015: Fourteen forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants, funded by the Movember Foundation through Prostate Cancer Canada (PCC).
More

Prostate Cancer Canada Raises Funds & Awareness for Canadian Men this Father’s Day

EDMONTON, ALBERTA – June 21st, 2015 – Friends, families and survivors from across the country joined Prostate Cancer Canada today to unite against prostate cancer.
More


Click here for news archive